Rhinomed is pleased to announce that the Australian Taxation Office has of today’s date refunded the R&D tax incentive amount in respect of the FY20 income tax year.
The Company had previously lodged an application with AusIndustry which was approved. The Company then submitted its FY20 tax return, detailing the R&D tax incentive refund amount.
- Rhinomed has received $185,124.98 through the R&D Tax Incentive
- Funds will be used for working capital requirements of the business